by Stacey Johnson | Sep 28, 2018
September is National Blood Cancer Awareness Month. “Few people know that many of today’s fundamental treatments for various cancers, like chemotherapy, began with blood cancer research,” explains Alicia Talarico, President, Leukemia & Lymphoma...
by Stacey Johnson | Jun 1, 2018
Are you familiar with The Conversation – not to be confused with The Conversation with Amanda De Cadenet? Amanda De Cadenet is one busy lady who makes television and online shows for, and about, women. The Conversation is a not-for-profit media outlet that publishes...
by Sara M. Nolte | May 19, 2015
. I’ve spent a number of posts going on and on about how targeting cancer stem cells (CSCs) is the next big thing for cancer therapies, and how important it is that we study and learn all we can about them (know your enemy, right?). All of this has probably left you...
by Sara M. Nolte | Mar 23, 2015
> I have previously written about the phrase “cancer stem cell,” and how it can be misleading for researchers and the public alike. As scientists, we go through great pains to be specific in our use of ‘cancer stem cell’ (CSC), referring to a cell that possesses...
by Mark Curtis | Feb 23, 2015
. Welcome to your deal review for the month of January. There was a mixed bag of news last month, which included financing activity, industry partnerships and research collaborations. The cell therapy tools industry was front and centre as NeoStem and Invetech struck...
Comments